Effectiveness of the low power laser as adjuvant therapy in patients with zoster herpes
Keywords:
zoster herpes, therapy by laser, low power laser.Abstract
Introduction: The low power laser has a wide use in the current medical practice. There is a great number of patients with acute or chronic conditions that can be treated with this therapy, with encouraging results, far better than those obtained with the use of conventional therapy.
Objective: To evaluate the effectiveness of low power laser as adjuvant therapy to reduce the response time to pain relief in patients with zoster herpes.
Methods: A quasi-experiment study of therapeutic intervention was carried out in 21 patients with zoster herpes. They were assisted in the Physical Medicine Service of the MININT Polyclinic in Santiago de Cuba, from January, 2016 to June, 2017. Two groups were conformed at random: the members of the first one received acyclovir, vitamins and lasertherapy (intervention); those of the second group received acyclovir, vitamins and analgesic (control).
Results: It was observed that in the intervention group the intensity of the pain was diminishing in connection with the initial evaluation. This way, in the fifth session it was appreciated a higher percentage of patients with pain relief that in the control group, the same as in the tenth session and 21 days later, hence the effectiveness of the treatment.
Conclusions: With the use of low power laser the patients with zoster herpes presented an improvement of the pain in less time, with a satisfactory response expressed in all of them, reason why its use is recommended as adjuvant therapy.
Downloads
References
2. Morales Polanco I, Coutin Marie G. Herpes zóster: caracterización clínico-epidemiológica. Tendencia en Cuba y expectativas. Reporte Técnico de Vigilancia. 2005 [citado 04/02/2020]; 10(1). Disponible en: https://es.scribd.com/document/244803314/Herpes-Zóster-Caracterizacion-Clinico-Epidemiologica-Tendencia-en-Cuba-y-Expectativas
3. Velázquez Zuñiga GA, Osorio Serrano M, Báster Moro JC. Problemas más frecuentes de la piel y las faneras. En: Álvarez Sintes R, Hernández Cabrera G, Báster Moro JC, García Núñez RD, Martínez Góme C, Jiménez Acosta S. Medicina General Integral. 3ed. La Habana: Editorial Ciencias Médicas; 2014.p.1733-44.
4. Garrido Suárez B, Yera Nadal JL. Neuralgia por herpes zóster. En: Yera Nadal JL. Temas de Medicina del Dolor. La Habana: Editorial Ciencias Médicas; 2017.p.158-79.
5. Calvo Mosquera G, González Cal A, Calvo Rodríguez D, Primucci CY, Plamenov Dipchikov P. Dolor en el herpes zóster: prevención y tratamiento. Medicina de familia. SEMERGEN. 2017 [citado 04/02/2020];43(4):318-27. Disponible en: https://www.elsevier.es/es-revista-medicina-familia-semergen-40-articulo-dolor-el-herpes-zóster-prevencion-S1138359316000800
6. Chacón Gonzáles C, Rivera Fumero S, González Chavarría A. Actualización del herpes zóster. Rev Méd Sinerg. 2020 [citado 04/02/2020];5(9):566. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/566
7. Le P, Rothberg M. Herpes Zóster infection. BMJ. 2019 [citado 04/02/2020];364. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30630827/
8. John AR, Canaday DH. Herpes Zóster in the Older Adult. Infect Dis Clin North Am. 2017 [citado 04/02/2020];31(4):811-26. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724974/
9. Alvarado Ferllini M, Medina Correa NV, Quesada Musa C. Síndrome de Ramsay Hung: una temida presentación del herpes zóster. Rev Méd Sinerg. 2020 [citado 04/02/2020];5(6):1-13. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/416
10. García González AI, Rosas Carrasco O. Herpes zóster (HZ) y neuralgia posherpética (NPH) en el adulto mayor: particularidades en la prevención, el diagnóstico y el tratamiento. Gac Med Mex. 2017 [citado 04/02/2020];153:92-101. Disponible en: https://www.anmm.org.mx/GMM/2017/n1/GMM_153_2017_1_092-101.pdf
11. Láser terapia de baja intensidad. EcuRed [citado 04/02/2020]. Disponible en: https://www.ecured.cu/L%C3%A1ser_terapia_de_baja_instensidad
12. Bardach AE, Palermo C, Alconada T, Sandoval M, Balan DJ, Nieto Guevara J, et al. Herpes zóster epidemiology in Latin America: A systematic review and meta-analysis. PLoS ONE 2021 [citado 04/02/2020]; 16(8). Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255877
13. Valverde López J. Herpes virus. Dermatol Perú. 2017 [citado 04/02/2020];27(4):212-24. Disponible en: https://www.dermatologiaperuana.pe/assets/uploads/revista_R4sQ_03_articulo_revision_rev_derma_27-4.pdf
14. Centro Nacional de Epidemiología. CIBERESP. Instituto de Salud Carlos III. Informe epidemiológico sobre la situación del Herpes Zóster en España, 1998-2018. Madrid: CNE;2020 [citado 04/02/2020]. https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/archivos%20A-Z/HERPES%20ZÓSTER/Informe_HZ_Espa%C3%B1a_1998-2018.pdf
15. Martín Cordero JE, Bravo Acosta T, Capote Cabrera A, González Roig JL, Hernández Tápanes S, Martínez Aparicio Hernández A, et al. Laserterapia. En: Agentes físicos terapéuticos. 2ed. La Habana: Editorial Ciencias Médicas; 2010.p.95-428.
16. Martínez Morillo M, Sendra Portero F. Láser. En: Manual de Medicina Física. Madrid: Harcourt; 1998.
17. Ribeiro Costa D, Ribeiro Costa D, Rodrigues Pessoa D, Alves Delpasso C, Amadei Nicolau R. Bases fisiopatológicas da aplicacão da terapia a laser de baixa intensidade no herpes zóster e neuralgia pós-herpética com acometimento orofacial. Rev Univap. 2017[citado 04/02/2020];23(43):26 Disponible en: https://revista.univap.br/index.php/revistaunivap/article/view/1873
18. Ruiz Martínez MC, Fernández Ramírez I, Bordelois Abdo JA, Chacón Benítez O, Vega Puente JO, Romero Frómeta R. Aplicación de laserterapia en herpes zóster. Rev Inf Cient. 2006 [citado 17/10/2020]; 50(2). Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/1477
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
